nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyruvic acid—SLC16A8—age related macular degeneration	0.851	1	CbGaD
Pyruvic acid—SLC16A7—Proton-coupled monocarboxylate transport—SLC16A8—age related macular degeneration	0.0162	0.157	CbGpPWpGaD
Pyruvic acid—SLC16A3—Proton-coupled monocarboxylate transport—SLC16A8—age related macular degeneration	0.0128	0.124	CbGpPWpGaD
Pyruvic acid—SLC16A3—optic choroid—age related macular degeneration	0.0085	0.186	CbGeAlD
Pyruvic acid—SLC16A1—Proton-coupled monocarboxylate transport—SLC16A8—age related macular degeneration	0.00692	0.0668	CbGpPWpGaD
Pyruvic acid—SLC16A7—Bile salt and organic anion SLC transporters—SLC16A8—age related macular degeneration	0.00673	0.065	CbGpPWpGaD
Pyruvic acid—PDHB—Pyruvate metabolism—SLC16A8—age related macular degeneration	0.00625	0.0605	CbGpPWpGaD
Pyruvic acid—SLC16A3—Bile salt and organic anion SLC transporters—SLC16A8—age related macular degeneration	0.00532	0.0514	CbGpPWpGaD
Pyruvic acid—SLC16A8—eye—age related macular degeneration	0.00459	0.101	CbGeAlD
Pyruvic acid—SLC16A8—retina—age related macular degeneration	0.00455	0.0996	CbGeAlD
Pyruvic acid—PDHB—Pyruvate metabolism and Citric Acid (TCA) cycle—SLC16A8—age related macular degeneration	0.00378	0.0366	CbGpPWpGaD
Pyruvic acid—SLC16A3—Pyruvate metabolism—SLC16A8—age related macular degeneration	0.00305	0.0295	CbGpPWpGaD
Pyruvic acid—SLC16A3—Basigin interactions—SLC16A8—age related macular degeneration	0.00296	0.0286	CbGpPWpGaD
Pyruvic acid—SLC16A1—Bile salt and organic anion SLC transporters—SLC16A8—age related macular degeneration	0.00287	0.0278	CbGpPWpGaD
Pyruvic acid—PDHB—eye—age related macular degeneration	0.00243	0.0531	CbGeAlD
Pyruvic acid—PDHB—retina—age related macular degeneration	0.0024	0.0526	CbGeAlD
Pyruvic acid—PDHB—connective tissue—age related macular degeneration	0.00234	0.0512	CbGeAlD
Pyruvic acid—PKM—eye—age related macular degeneration	0.00231	0.0507	CbGeAlD
Pyruvic acid—PKM—retina—age related macular degeneration	0.00229	0.0502	CbGeAlD
Pyruvic acid—PKM—connective tissue—age related macular degeneration	0.00223	0.0488	CbGeAlD
Pyruvic acid—PC—eye—age related macular degeneration	0.00214	0.0468	CbGeAlD
Pyruvic acid—PC—connective tissue—age related macular degeneration	0.00206	0.0451	CbGeAlD
Pyruvic acid—PC—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.00188	0.0182	CbGpPWpGaD
Pyruvic acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—SLC16A8—age related macular degeneration	0.00185	0.0179	CbGpPWpGaD
Pyruvic acid—SLC16A3—eye—age related macular degeneration	0.00171	0.0375	CbGeAlD
Pyruvic acid—SLC16A3—retina—age related macular degeneration	0.0017	0.0371	CbGeAlD
Pyruvic acid—SLC16A1—Pyruvate metabolism—SLC16A8—age related macular degeneration	0.00165	0.0159	CbGpPWpGaD
Pyruvic acid—SLC16A1—Basigin interactions—SLC16A8—age related macular degeneration	0.0016	0.0154	CbGpPWpGaD
Pyruvic acid—ABAT—eye—age related macular degeneration	0.00155	0.034	CbGeAlD
Pyruvic acid—ABAT—retina—age related macular degeneration	0.00154	0.0337	CbGeAlD
Pyruvic acid—PDHB—The citric acid (TCA) cycle and respiratory electron transport—SLC16A8—age related macular degeneration	0.00147	0.0142	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00126	0.0122	CbGpPWpGaD
Pyruvic acid—SLCO2A1—eye—age related macular degeneration	0.00125	0.0274	CbGeAlD
Pyruvic acid—SLC16A1—eye—age related macular degeneration	0.00104	0.0228	CbGeAlD
Pyruvic acid—SLC16A1—retina—age related macular degeneration	0.00103	0.0226	CbGeAlD
Pyruvic acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.000999	0.00966	CbGpPWpGaD
Pyruvic acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—SLC16A8—age related macular degeneration	0.000997	0.00964	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—SLC16A8—age related macular degeneration	0.000983	0.0095	CbGpPWpGaD
Pyruvic acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—SLC16A8—age related macular degeneration	0.000716	0.00693	CbGpPWpGaD
Pyruvic acid—SLC16A7—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.000574	0.00555	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—F13B—age related macular degeneration	0.000546	0.00528	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00054	0.00522	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—SLC16A8—age related macular degeneration	0.000531	0.00513	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—SERPING1—age related macular degeneration	0.000513	0.00496	CbGpPWpGaD
Pyruvic acid—SLCO2A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.000502	0.00485	CbGpPWpGaD
Pyruvic acid—SLC16A3—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.000454	0.00439	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—RAD51B—age related macular degeneration	0.000445	0.0043	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000402	0.00388	CbGpPWpGaD
Pyruvic acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SLC16A8—age related macular degeneration	0.000387	0.00374	CbGpPWpGaD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00037	0.00358	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000358	0.00346	CbGpPWpGaD
Pyruvic acid—PKM—Disease—NMNAT1—age related macular degeneration	0.000353	0.00341	CbGpPWpGaD
Pyruvic acid—PKM—Disease—RDH8—age related macular degeneration	0.000353	0.00341	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—F13B—age related macular degeneration	0.000352	0.0034	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—SERPING1—age related macular degeneration	0.000331	0.0032	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000327	0.00317	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—NMNAT1—age related macular degeneration	0.000314	0.00304	CbGpPWpGaD
Pyruvic acid—PKM—Disease—RPE65—age related macular degeneration	0.000308	0.00298	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—NMNAT1—age related macular degeneration	0.000295	0.00285	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000292	0.00282	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000292	0.00282	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—RAD51B—age related macular degeneration	0.000287	0.00277	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000286	0.00277	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—RDH8—age related macular degeneration	0.000284	0.00275	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—NMNAT1—age related macular degeneration	0.000284	0.00275	CbGpPWpGaD
Pyruvic acid—SLC16A10—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.000276	0.00267	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—ELOVL4—age related macular degeneration	0.000275	0.00265	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—SLC16A8—age related macular degeneration	0.000267	0.00258	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000259	0.0025	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—ELOVL4—age related macular degeneration	0.000258	0.00249	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000255	0.00247	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000255	0.00247	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—RPE65—age related macular degeneration	0.000248	0.0024	CbGpPWpGaD
Pyruvic acid—PKM—Disease—ABCA4—age related macular degeneration	0.000248	0.0024	CbGpPWpGaD
Pyruvic acid—SLC16A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.000245	0.00237	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—NMNAT1—age related macular degeneration	0.000238	0.0023	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—NMNAT1—age related macular degeneration	0.000238	0.0023	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000231	0.00223	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000231	0.00223	CbGpPWpGaD
Pyruvic acid—PC—Disease—RDH8—age related macular degeneration	0.000223	0.00216	CbGpPWpGaD
Pyruvic acid—PC—Disease—NMNAT1—age related macular degeneration	0.000223	0.00216	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—SLC16A8—age related macular degeneration	0.000221	0.00214	CbGpPWpGaD
Pyruvic acid—PKM—Disease—RHO—age related macular degeneration	0.000216	0.00209	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—ELOVL4—age related macular degeneration	0.000208	0.00201	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—ELOVL4—age related macular degeneration	0.000208	0.00201	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—SLC16A8—age related macular degeneration	0.000208	0.00201	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—NMNAT1—age related macular degeneration	0.000202	0.00196	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—ABCA4—age related macular degeneration	0.0002	0.00194	CbGpPWpGaD
Pyruvic acid—PC—Disease—RPE65—age related macular degeneration	0.000195	0.00188	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—F13B—age related macular degeneration	0.00019	0.00184	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—NMNAT1—age related macular degeneration	0.000187	0.00181	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SERPING1—age related macular degeneration	0.000179	0.00173	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—ELOVL4—age related macular degeneration	0.000177	0.00171	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000177	0.00171	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—RHO—age related macular degeneration	0.000174	0.00168	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—SLC16A8—age related macular degeneration	0.000168	0.00162	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—ELOVL4—age related macular degeneration	0.000163	0.00158	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000157	0.00152	CbGpPWpGaD
Pyruvic acid—PC—Disease—ABCA4—age related macular degeneration	0.000157	0.00152	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—RAD51B—age related macular degeneration	0.000155	0.0015	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—NMNAT1—age related macular degeneration	0.000153	0.00148	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000144	0.00139	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SLC16A8—age related macular degeneration	0.000144	0.00139	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—SLC16A8—age related macular degeneration	0.000143	0.00138	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00014	0.00136	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00014	0.00136	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00014	0.00135	CbGpPWpGaD
Pyruvic acid—PC—Disease—RHO—age related macular degeneration	0.000137	0.00132	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CST3—age related macular degeneration	0.000135	0.00131	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—ELOVL4—age related macular degeneration	0.000134	0.0013	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—SLC16A8—age related macular degeneration	0.000132	0.00127	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000126	0.00122	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—CD36—age related macular degeneration	0.000125	0.00121	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000125	0.0012	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000125	0.0012	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—CD36—age related macular degeneration	0.000123	0.00119	CbGpPWpGaD
Pyruvic acid—PKM—Disease—TGFBR1—age related macular degeneration	0.000121	0.00117	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000114	0.0011	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—LIPC—age related macular degeneration	0.000113	0.00109	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CETP—age related macular degeneration	0.000109	0.00106	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CST3—age related macular degeneration	0.000109	0.00105	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—KDR—age related macular degeneration	0.000108	0.00105	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—SLC16A8—age related macular degeneration	0.000108	0.00104	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—LIPC—age related macular degeneration	0.000107	0.00103	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CETP—age related macular degeneration	0.000103	0.000993	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TGFBR1—age related macular degeneration	9.78e-05	0.000945	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—LIPC—age related macular degeneration	8.58e-05	0.00083	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—LIPC—age related macular degeneration	8.58e-05	0.00083	CbGpPWpGaD
Pyruvic acid—PC—Disease—CST3—age related macular degeneration	8.55e-05	0.000826	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CETP—age related macular degeneration	8.28e-05	0.000801	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CETP—age related macular degeneration	8.28e-05	0.000801	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—NMNAT1—age related macular degeneration	8.28e-05	0.000801	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—CD36—age related macular degeneration	7.91e-05	0.000765	CbGpPWpGaD
Pyruvic acid—PC—Disease—TGFBR1—age related macular degeneration	7.67e-05	0.000742	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—LIPC—age related macular degeneration	7.3e-05	0.000706	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—ELOVL4—age related macular degeneration	7.24e-05	0.0007	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CETP—age related macular degeneration	7.04e-05	0.000681	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—CETP—age related macular degeneration	6.93e-05	0.000669	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—LIPC—age related macular degeneration	6.74e-05	0.000651	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CD36—age related macular degeneration	6.57e-05	0.000635	CbGpPWpGaD
Pyruvic acid—PKM—Disease—APOE—age related macular degeneration	6.5e-05	0.000629	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CETP—age related macular degeneration	6.5e-05	0.000628	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CD36—age related macular degeneration	6.18e-05	0.000597	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	6.15e-05	0.000595	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—VEGFA—age related macular degeneration	5.96e-05	0.000576	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—VEGFA—age related macular degeneration	5.85e-05	0.000565	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—SLC16A8—age related macular degeneration	5.84e-05	0.000564	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—APOE—age related macular degeneration	5.79e-05	0.00056	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—LIPC—age related macular degeneration	5.53e-05	0.000535	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—APOE—age related macular degeneration	5.45e-05	0.000527	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CETP—age related macular degeneration	5.34e-05	0.000516	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—APOE—age related macular degeneration	5.24e-05	0.000507	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CD36—age related macular degeneration	4.98e-05	0.000481	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CD36—age related macular degeneration	4.98e-05	0.000481	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—APOE—age related macular degeneration	4.39e-05	0.000424	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—APOE—age related macular degeneration	4.39e-05	0.000424	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—CD36—age related macular degeneration	4.27e-05	0.000413	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CD36—age related macular degeneration	4.23e-05	0.000409	CbGpPWpGaD
Pyruvic acid—PC—Disease—APOE—age related macular degeneration	4.11e-05	0.000398	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CD36—age related macular degeneration	3.91e-05	0.000378	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—VEGFA—age related macular degeneration	3.77e-05	0.000364	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—APOE—age related macular degeneration	3.73e-05	0.000361	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—APOE—age related macular degeneration	3.45e-05	0.000333	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CD36—age related macular degeneration	3.21e-05	0.00031	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—LIPC—age related macular degeneration	2.99e-05	0.000289	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CETP—age related macular degeneration	2.88e-05	0.000279	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—APOE—age related macular degeneration	2.83e-05	0.000274	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—VEGFA—age related macular degeneration	2.03e-05	0.000197	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CD36—age related macular degeneration	1.73e-05	0.000167	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—APOE—age related macular degeneration	1.53e-05	0.000148	CbGpPWpGaD
